4-(Tri-n-butylstannyl)thiazole → HCID 57634245, compound

HRID 2109455Notes

Reaction equation

HRID 2109455 reaction equation
Br[C:2]1[O:6][C:5]([N:7]2[CH2:11][C@:10]3([CH:16]4[CH2:17][CH2:18][N:13]([CH2:14][CH2:15]4)[CH2:12]3)[O:9][C:8]2=[O:19])=[CH:4][CH:3]=1.C([Sn](CCCC)(CCCC)[C:25]1[N:26]=[CH:27][S:28][CH:29]=1)CCC>>[S:28]1[CH:29]=[C:25]([C:2]2[O:6][C:5]([N:7]3[CH2:11][C@:10]4([CH:16]5[CH2:17][CH2:18][N:13]([CH2:14][CH2:15]5)[CH2:12]4)[O:9][C:8]3=[O:19])=[CH:4][CH:3]=2)[N:26]=[CH:27]1

Participants

3

Reactant 2

HCID 27632584-(Tri-n-butylstannyl)thiazoleHCID 57634251HCID 57634251, compound

Product 1

HCID 57634245HCID 57634245, compound

Procedure

The title compound was prepared by a method analogous to that described in Example 14 from (R)-3′-(5-bromofuran-2-yl)spiro[1-azabicyclo[2.2.2]octan-3,5′-oxazolidin]-2′-one and 4-(tri-n-butylstannyl)thiazole. The title compound (81 mg) was obtained as a pale solid, m/z 332 (MH+).

Workup

  1. customThe title compound was prepared by a method analogous to

Sources & evidence

ORD record
ord-7ef64e3e5d364ef9a2fcc0e3bc55d920
Source dataset
uspto-grants-2009_04
Patent number
US07514567B2

Reaction notes

Loading…